Literature DB >> 28108192

Epidemiology and Pathophysiology of Childhood Narcolepsy.

Thomas J Dye1, Neepa Gurbani1, Narong Simakajornboon2.   

Abstract

It is now recognized that there are two types of narcolepsy. Narcolepsy type I or Narcolepsy with cataplexy is caused by the loss of hypocretin or orexin neurons. Narcolepsy type II or narcolepsy without cataplexy has normal hypocretin and the etiology is unknown. Hypocretin is a neuropeptide produced by neurons in the lateral hypothalamus. Both genetic and environmental factors play a crucial role in the pathogenesis of narcolepsy. Most patients with narcolepsy type I and half of patients with narcolepsy type II carry HLA-DQB1*0602. HLA-DQB1*0602 forms a heterodimer with HLA-DQA1*0102 and may act as an antigen presenter to the T cell receptors, resulting in narcolepsy susceptibility. In addition, narcolepsy has been shown to be linked to polymorphisms in other non-HLA genes that may affect immune regulatory function, leading to speculation that autoimmune processes may play a crucial role in the loss of hypocretin neurons. Infections have been proposed as a potential trigger for the autoimmune-mediated mechanism. Several recent studies have shown increased cases of narcolepsy, especially in children and adolescents in relation with H1N1 influenza. The increased cases in Europe seems to be related to a specific type of H1N1 influenza vaccination (Pandemrix), while the increased cases in China are related to influenza infection. The data from the Pediatric Working Group of the Sleep Research Network have shown similar increases of early onset narcolepsy in the United States.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Autoimmune mechanism; Childhood narcolepsy; H1N1 pandemic; H1N1 vaccination; HLA; Narcolepsy; Narcolepsy epidemiology; Narcolepsy genetics; Narcolepsy pathogenesis; Narcolepsy with cataplexy; Streptococcal infection

Mesh:

Substances:

Year:  2016        PMID: 28108192     DOI: 10.1016/j.prrv.2016.12.005

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  13 in total

Review 1.  Sleep disorders during childhood: a practical review.

Authors:  D Ophoff; M A Slaats; A Boudewyns; I Glazemakers; K Van Hoorenbeeck; S L Verhulst
Journal:  Eur J Pediatr       Date:  2018-03-03       Impact factor: 3.183

Review 2.  Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder.

Authors:  Maria Pia Giannoccaro; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Nat Sci Sleep       Date:  2021-05-11

3.  Characterization of rapid weight gain phenotype in children with narcolepsy.

Authors:  Min Zhang; Marine Thieux; Clara Odilia Inocente; Noemie Vieux; Laura Arvis; Carine Villanueva; Jian-Sheng Lin; Sabine Plancoulaine; Aurore Guyon; Patricia Franco
Journal:  CNS Neurosci Ther       Date:  2022-02-25       Impact factor: 7.035

4.  Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.

Authors:  Guo Luo; Ling Lin; Louis Jacob; Mélodie Bonvalet; Aditya Ambati; Giuseppe Plazzi; Fabio Pizza; Ryan Leib; Christopher M Adams; Markku Partinen; Emmanuel Jean-Marie Mignot
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

5.  Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Authors:  Guo Luo; Aditya Ambati; Ling Lin; Mélodie Bonvalet; Markku Partinen; Xuhuai Ji; Holden Terry Maecker; Emmanuel Jean-Marie Mignot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

Review 6.  Narcolepsy in Children and Adults: A Guide to Improved Recognition, Diagnosis and Management.

Authors:  Anne Marie Morse
Journal:  Med Sci (Basel)       Date:  2019-11-27

Review 7.  Narcolepsy Presentation in Diverse Populations: an Update.

Authors:  Karen Spruyt
Journal:  Curr Sleep Med Rep       Date:  2020-11-25

Review 8.  A practical guide to the pharmacological and behavioral therapy of Narcolepsy.

Authors:  Christian Franceschini; Fabio Pizza; Francesca Cavalli; Giuseppe Plazzi
Journal:  Neurotherapeutics       Date:  2021-04-22       Impact factor: 7.620

9.  Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan.

Authors:  Jia-Yin Yeh; Yu-Chiau Shyu; Sheng-Yu Lee; Shin-Sheng Yuan; Chun-Ju Yang; Kang-Chung Yang; Tung-Liang Lee; Chi-Chin Sun; Liang-Jen Wang
Journal:  Front Psychiatry       Date:  2020-03-25       Impact factor: 4.157

Review 10.  Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review.

Authors:  Stephanie P Fabara; Juan Fernando Ortiz; Anas Anas Sohail; Jessica Hidalgo; Abbas Altamimi; Belen Tama; Urvish K Patel
Journal:  Cureus       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.